Clinical Trial Update: A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled trial evaluating the safety and efficacy of MSDC-0160 in adults with Type 2 Diabetes Mellitus, including an active comparator. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MSDC-0160

Snippet

Sponsor: Metabolic Solutions Development Company | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2013-05-03